Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 48.05
-0.20 (-0.41%)
Feb 28, 2025, 4:00 PM CST
SHA:688192 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | - | 74.2 | 121.67 | 364.24 | 509.02 | Upgrade
|
| Trading Asset Securities | - | 674 | 1,295 | 1,711 | 90.29 | Upgrade
|
| Cash & Short-Term Investments | 808.3 | 748.2 | 1,416 | 2,075 | 599.31 | Upgrade
|
| Cash Growth | 8.03% | -47.18% | -31.74% | 246.26% | 173.26% | Upgrade
|
| Accounts Receivable | - | 48.04 | - | 7.55 | 6.9 | Upgrade
|
| Receivables | - | 48.04 | - | 7.55 | 6.9 | Upgrade
|
| Inventory | - | 23.47 | 5.07 | - | - | Upgrade
|
| Other Current Assets | - | 90.65 | 51.64 | 29.57 | 18.86 | Upgrade
|
| Total Current Assets | - | 910.36 | 1,473 | 2,112 | 625.07 | Upgrade
|
| Property, Plant & Equipment | - | 102.26 | 103.66 | 104.48 | 15.19 | Upgrade
|
| Other Intangible Assets | - | 461.98 | 492.02 | 474.9 | 506.25 | Upgrade
|
| Long-Term Deferred Charges | - | 16.99 | 7.99 | 4.54 | 3.53 | Upgrade
|
| Other Long-Term Assets | - | 4.79 | 5.06 | 49.51 | 31.98 | Upgrade
|
| Total Assets | - | 1,496 | 2,082 | 2,746 | 1,182 | Upgrade
|
| Accounts Payable | - | 20.22 | 8.81 | 1.65 | 1.06 | Upgrade
|
| Accrued Expenses | - | 177.08 | 208.53 | 182.75 | 94.26 | Upgrade
|
| Short-Term Debt | - | 200.11 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.1 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 22.95 | 21.34 | 16.84 | - | Upgrade
|
| Current Income Taxes Payable | - | 0.05 | 0 | - | 0.01 | Upgrade
|
| Current Unearned Revenue | - | 0.98 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 26.93 | 9.82 | 10.76 | 7.79 | Upgrade
|
| Total Current Liabilities | - | 448.44 | 248.49 | 211.99 | 103.11 | Upgrade
|
| Long-Term Debt | - | 138.31 | - | - | - | Upgrade
|
| Long-Term Leases | - | 48.89 | 63.93 | 70.92 | - | Upgrade
|
| Long-Term Unearned Revenue | - | 12.11 | 11 | - | - | Upgrade
|
| Total Liabilities | - | 647.75 | 323.43 | 282.91 | 103.11 | Upgrade
|
| Common Stock | - | 408.15 | 407.16 | 404.18 | 360 | Upgrade
|
| Additional Paid-In Capital | - | 2,954 | 2,757 | 2,729 | 718.88 | Upgrade
|
| Retained Earnings | - | -2,514 | -1,406 | -669.85 | 0.03 | Upgrade
|
| Total Common Equity | 428.43 | 848.63 | 1,758 | 2,463 | 1,079 | Upgrade
|
| Shareholders' Equity | 437.25 | 848.63 | 1,758 | 2,463 | 1,079 | Upgrade
|
| Total Liabilities & Equity | - | 1,496 | 2,082 | 2,746 | 1,182 | Upgrade
|
| Total Debt | 903.95 | 410.37 | 85.27 | 87.76 | - | Upgrade
|
| Net Cash (Debt) | -95.65 | 337.83 | 1,331 | 1,987 | 599.31 | Upgrade
|
| Net Cash Growth | - | -74.62% | -33.02% | 231.62% | 173.26% | Upgrade
|
| Net Cash Per Share | -0.23 | 0.83 | 3.29 | 5.52 | 1.67 | Upgrade
|
| Filing Date Shares Outstanding | 417.65 | 408.15 | 407.16 | 404.18 | 360 | Upgrade
|
| Total Common Shares Outstanding | 417.65 | 408.15 | 407.16 | 404.18 | 360 | Upgrade
|
| Working Capital | - | 461.93 | 1,225 | 1,900 | 521.97 | Upgrade
|
| Book Value Per Share | 1.03 | 2.08 | 4.32 | 6.09 | 3.00 | Upgrade
|
| Tangible Book Value | -9.43 | 386.65 | 1,266 | 1,988 | 572.66 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | 0.95 | 3.11 | 4.92 | 1.59 | Upgrade
|
| Machinery | - | 49.14 | 31.99 | 26.91 | 23.59 | Upgrade
|
| Construction In Progress | - | 13.35 | 8.85 | 5.04 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.